Skip to main content

Table 1 Effective dose from the 55 radiopharmaceuticals in ICRP publication 106, determined using three different methods

From: Erratum to: Effective dose to adult patients from 338 radiopharmaceuticals estimated using ICRP biokinetic data, ICRP/ICRU computational reference phantoms and ICRP 2007 tissue weighting factors

Radiopharmaceuticals (E/A0)1 [mSv/MBq] (E/A0)2 [mSv/MBq] ((E/A0)2-(E/A0)1)/(E/A0)1 [%] (E/A0)3 [mSv/MBq] ((E/A0)3-(E/A0)1)/(E/A0)1 [%] (E/A0)3 male [mSv/MBq] (E/A0)3 female [mSv/MBq]
Phantom MIRD ICRP/ICRU   ICRP/ICRU   ICRP/ICRU ICRP/ICRU
wT ICRP 60 ICRP 60   ICRP 103   ICRP 103 ICRP 103
3H Tritium labelled neutral fat & free fatty acids 2.2E-01 9.81E-02 −55 1.80E-01 −18 2.44E-01 1.16E-01
11C Carbon acetate 3.5E-03 4.26E-03 22 3.65E-03 4 3.33E-03 3.97E-03
11C Carbon amino acids 5.6E-03 5.76E-03 3 5.26E-03 −6 4.91E-03 5.61E-03
11C Carbon brain receptor substances 4.3E-03 3.70E-03 −14 3.62E-03 −16 3.23E-03 4.00E-03
11C Carbon methionine 8.4E-03 5.88E-03 −30 5.11E-03 −39 4.50E-03 5.72E-03
11C Carbon (2-11C)thymidine 2.7E-03 3.01E-03 11 3.04E-03 13 2.77E-03 3.32E-03
11C Carbon, realistic maximum 1.1E-02 6.04E-03 −45 5.08E-03 −54 4.36E-03 5.80E-03
14C Carbon labelled neutral fat & free fatty acids 2.1E + 00 1.88E + 00 −10 2.65E + 00 26 3.14E + 00 2.15E + 00
14C Carbon labelled urea, normal case, orally administered 3.1E-02 2.67E-02 −14 2.72E-02 −12 2.46E-02 2.98E-02
15O Oxygen water 1.1E-03 9.63E-04 −12 9.33E-04 −15 8.72E-04 9.93E-04
18 F Fluoride labelled amino acids 2.3E-02 2.27E-02 −1 2.07E-02 −10 1.92E-02 2.21E-02
18 F Fluoride labelled brain receptor substances 2.8E-02 2.01E-02 −28 2.02E-02 −28 1.82E-02 2.22E-02
18 F Fluoride FDG 1.9E-02 1.69E-02 −11 1.71E-02 −10 1.53E-02 1.88E-02
18 F Fluoride L-dopa 2.5E-02 1.75E-02 −30 1.57E-02 −37 1.37E-02 1.76E-02
51Cr Chromium EDTA 2.0E-03 1.65E-03 −18 1.43E-03 −29 1.23E-03 1.62E-03
67Ga Gallium citrate 1.0E-01 9.29E-02 −7 9.08E-02 −9 8.14E-02 1.00E-01
68Ga Gallium labelled EDTA 4.0E-02 2.41E-02 −40 2.14E-02 −47 1.89E-02 2.40E-02
75Se Selenium labelled amino acids 2.2E + 00 2.39E + 00 8 2.27E + 00 3 2.14E + 00 2.39E + 00
75Se Selenium labelled bile acid SeHCAT 6.9E-01 3.01E-01 −56 3.48E-01 −50 3.16E-01 3.79E-01
99mTc Technetium apcitide 4.7E-03 1.13E-02 140 1.19E-02 153 1.10E-02 1.29E-02
99mTc Technetium labelled small colloids, intratumoural adm. time to removal 18 h 2.0E-03 3.14E-03 57 3.96E-03 98 3.49E-03 4.43E-03
99mTc Technetium labelled small colloids, intratumoural adm time to removal 6 h 1.2E-03 1.78E-03 48 2.24E-03 86 1.98E-03 2.50E-03
99mTc Technetium EC, normal renal function 6.3E-03 4.63E-03 −27 3.66E-03 −42 3.04E-03 4.29E-03
99mTc Technetium ECD 7.7E-03 5.97E-03 −23 5.64E-03 −27 5.01E-03 6.27E-03
99mTc Technetium furifosmin, exercise 8.9E-03 6.57E-03 −26 6.78E-03 −24 6.16E-03 7.40E-03
99mTc Technetium furifosmin, resting subject 1.0E-02 6.99E-03 −30 7.19E-03 −28 6.53E-03 7.85E-03
99mTc Technetium labelled HIG 7.0E-03 9.83E-03 40 9.42E-03 35 8.93E-03 9.92E-03
99mTc Technetium labelled HM-PAO 9.3E-03 1.05E-02 13 9.78E-03 5 8.95E-03 1.06E-02
Tc-99 m Technetium labelled IDA derivatives, normal hepato-biliary conditions 1.7E-02 9.39E-03 −45 9.73E-03 −43 8.93E-03 1.05E-02
99mTc Technetium labelled MAA 1.1E-02 1.34E-02 22 1.40E-02 27 1.27E-02 1.53E-02
99mTc Technetium labelled MAG3, normal renal function 7.0E-03 5.12E-03 −27 4.00E-03 −43 3.29E-03 4.70E-03
99mTc Technetium labelled non-absorbable markers, orally administered fluids 1.9E-02 1.06E-02 −44 1.07E-02 −44 9.93E-03 1.14E-02
99mTc Technetium labelled non-absorbable markers, orally administered solids 2.4E-02 1.13E-02 −53 1.15E-02 −52 1.07E-02 1.24E-02
99mTc Technetium labelled MIBI, exercise 7.9E-03 6.55E-03 −17 6.29E-03 −20 5.80E-03 6.78E-03
99mTc Technetium labelled MIBI, resting subject 9.0E-03 6.81E-03 −24 6.61E-03 −27 6.14E-03 7.07E-03
99mTc Technetium labelled monoclonal antibodies, intact antibody 1.2E-02 1.17E-02 −3 1.08E-02 −10 9.95E-03 1.16E-02
99mTc Technetium pertechnegas 1.2E-02 1.52E-02 26 1.50E-02 25 1.39E-02 1.61E-02
99mTc Technetium pertechnetate, intravenous blocking agent given 4.2E-03 4.34E-03 3 4.02E-03 −4 3.58E-03 4.46E-03
99mTc Technetium pertechnetate, intravenous no blocking agent given 1.3E-02 1.60E-02 23 1.58E-02 22 1.48E-02 1.68E-02
99mTc Technetium pertechnetate orally, no blocking agent 1.4E-02 6.48E-03 −54 6.36E-03 −55 5.83E-03 6.89E-03
99mTc Technetium labelled phosphates and phosphonates, normal uptake and excretion 5.7E-03 4.55E-03 −20 3.99E-03 −30 3.38E-03 4.59E-03
99mTc Technetium labelled erythrocytes 7.0E-03 1.06E-02 51 1.11E-02 59 1.02E-02 1.20E-02
99mTc Technetium technegas 1.5E-02 1.79E-02 19 1.90E-02 27 1.71E-02 2.08E-02
99mTc Technetium tetrofosmin, exercise 6.9E-03 5.54E-03 −20 5.67E-03 −18 5.15E-03 6.20E-03
99mTc Technetium tetrofosmin, resting subject 8.0E-03 5.92E-03 −26 6.15E-03 −23 5.57E-03 6.72E-03
99mTc Technetium labelled white blood cells (leukocytes) 1.1E-02 1.28E-02 16 1.02E-02 −7 9.24E-03 1.12E-02
111In Indium labelled HIG 1.7E-01 2.23E-01 31 2.15E-01 26 1.99E-01 2.31E-01
111In Indium labelled monoclonal antibodies, intact antibody 3.3E-01 2.88E-01 −13 2.74E-01 −17 2.49E-01 2.99E-01
111In Indium octreotide 5.4E-02 6.74E-02 25 5.93E-02 10 5.34E-02 6.51E-02
123I Iodide, thyroid uptake 35 % 2.2E-01 2.59E-01 18 2.13E-01 −3 1.95E-01 2.30E-01
123I Iodine BMIPP 1.6E-02 1.70E-02 6 1.71E-02 7 1.56E-02 1.87E-02
123I Iodine IPPA 1.6E-02 1.72E-02 7 1.72E-02 8 1.56E-02 1.87E-02
123I Iodine labelled brain receptor substances 5.0E-02 3.60E-02 −28 3.65E-02 −27 3.30E-02 4.00E-02
123I Iodine Hippuran, normal renal function 1.2E-02 8.88E-03 −26 7.06E-03 −41 5.98E-03 8.15E-03
123I Iodine MIBG 1.3E-02 1.67E-02 28 1.67E-02 28 1.51E-02 1.82E-02
123I Iodine labelled monoclonal antibodies, intact antibody 2.9E-02 3.29E-02 13 2.94E-02 1 2.68E-02 3.21E-02
124I Iodide, thyroid uptake 35 % 1.5E + 01 1.41E + 01 −6 1.15E + 01 −23 1.05E + 01 1.25E + 01
125I Iodide, thyroid uptake 35 % 1.4E + 01 1.85E + 01 32 1.50E + 01 7 1.38E + 01 1.62E + 01
131I Iodide, thyroid uptake 35 % 2.4E + 01 2.68E + 01 11 2.15E + 01 −10 1.98E + 01 2.33E + 01
131I Iodine, Hippuran, normal renal function 5.2E-02 1.89E-02 −64 1.53E-02 −71 1.29E-02 1.78E-02
131I Iodine, labelled monoclonal antibodies, intact antibody 4.7E-01 4.40E-01 −6 3.59E-01 −24 3.26E-01 3.94E-01
131I Iodine NP59 1.8E + 00 2.02E + 00 12 1.74E + 00 −3 1.60E + 00 1.89E + 00
201Tl Thallium ion 1.4E-01 1.27E-01 −10 1.02E-01 −27 9.90E-02 1.05E-01